AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus. Following the preliminary clinical trial results of the Sputnik V vaccine showing more than 90% efficacy for protection against COVID-19, AstraZeneca will be testing one of the two human adenoviral vector components in [ ]
The post AstraZeneca to test component of Russia’s Sputnik V vaccine appeared first on Health Europa.
Thursday 21 January 2021
⁞
Sources